Basic Information
| RNALocate ID: | RLID:11002493 |
| RNA Symbol: | hsa-miR-374a-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-374a |
| RNA ID: | miRBase:MIMAT0000727 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24009880 |
| Tissue/Cell Line: | Human mast cell line (HMC-1) |
| Method: | Microarray |
| Description: | In the exosomes, 116 microRNAs were identified and 134 microRNAs were identified in the donor HMC-1 cells (Fig. 3a and 3b, Table I and Additional Information, Table S16). Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002032 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002033 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002034 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002035 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:01002036 | Nucleus | Neural progenitor cells | 21363885 |
| RLID:11002489 | Exosome | Serum | 18589210 |
| RLID:11002490 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11002491 | Exosome | Brain tissue | 23382797 |
| RLID:11002492 | Exosome | Plasma | 23663360 |
| RLID:11002494 | Exosome | Plasma|Serum | 24683445 |
| RLID:11002495 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000120 | Exosome | Seminal fluid | |
| RLID-D:11000415 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-374a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-45519 |
| MNDR | hsa-miR-374a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-45520 |
| MNDR | hsa-miR-374a-5p | Oral squamous cell carcinoma | MNDR-E-MI-45521 |
| MNDR | hsa-miR-374a-5p | Ovarian clear cell carcinoma | MNDR-E-MI-45522 |
| MNDR | hsa-miR-374a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-45523 |
| MNDR | hsa-miR-374a-5p | Lymphoma | MNDR-E-MI-45524 |
| MNDR | hsa-miR-374a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-45525 |
| MNDR | hsa-miR-374a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-45526 |
| MNDR | hsa-miR-374a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-45527 |
| MNDR | hsa-miR-374a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-45528 |
| MNDR | hsa-miR-374a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-45529 |
| MNDR | hsa-miR-374a-5p | Breast cancer luminal | MNDR-E-MI-45530 |
| MNDR | hsa-miR-374a-5p | Niemann-pick disease type c | MNDR-E-MI-45531 |
| MNDR | hsa-miR-374a-5p | Prostate cancer | MNDR-E-MI-45532 |
| MNDR | hsa-miR-374a-5p | Gastric cancer | MNDR-E-MI-45533 |
| MNDR | hsa-miR-374a-5p | Gastric lymphoma | MNDR-E-MI-45534 |
| MNDR | hsa-miR-374a-5p | Alzheimer disease | MNDR-E-MI-45535 |
| MNDR | hsa-miR-374a-5p | Intracranial aneurysm | MNDR-E-MI-45536 |
| MNDR | hsa-miR-374a-5p | Esophageal carcinoma | MNDR-E-MI-45537 |
| MNDR | hsa-miR-374a-5p | Dysautonomia familial | MNDR-E-MI-45538 |
| MNDR | hsa-miR-374a-5p | Cardiovascular disease | MNDR-E-MI-45539 |
| MNDR | hsa-miR-374a-5p | Parkinson disease | MNDR-E-MI-45540 |
| MNDR | hsa-miR-374a-5p | Machado-joseph disease | MNDR-E-MI-45541 |
| MNDR | hsa-miR-374a-5p | Niemann-pick disease | MNDR-E-MI-45542 |
| MNDR | hsa-miR-374a-5p | Basal-like breast cancer | MNDR-E-MI-45543 |
| MNDR | hsa-miR-374a-5p | Pancreatic cancer | MNDR-E-MI-45544 |
| MNDR | hsa-miR-374a-5p | Melanoma | MNDR-E-MI-45545 |
| MNDR | hsa-miR-374a-5p | Rectum adenocarcinoma | MNDR-E-MI-45546 |
| MNDR | hsa-miR-374a-5p | Nephroblastoma | MNDR-E-MI-45547 |
| MNDR | hsa-miR-374a-5p | Colon cancer | MNDR-E-MI-45548 |
| MNDR | hsa-miR-374a-5p | Hypoxia-ischemia brain | MNDR-E-MI-45549 |
| MNDR | hsa-miR-374a-5p | Colon adenocarcinoma | MNDR-E-MI-45550 |
| MNDR | hsa-miR-374a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-45551 |
| MNDR | hsa-miR-374a-5p | Prostate adenocarcinoma | MNDR-E-MI-45552 |
| MNDR | hsa-miR-374a-5p | Glioblastoma | MNDR-E-MI-45553 |
| MNDR | hsa-miR-374a-5p | Glioma | MNDR-E-MI-45554 |
| MNDR | hsa-miR-374a-5p | Oligodendroglioma | MNDR-E-MI-45555 |
| MNDR | hsa-miR-374a-5p | Epilepsy temporal lobe | MNDR-E-MI-45556 |
| MNDR | hsa-miR-374a-5p | Osteosarcoma | MNDR-E-MI-45557 |
| MNDR | hsa-miR-374a-5p | Liposarcoma | MNDR-E-MI-45558 |
| MNDR | hsa-miR-374a-5p | Meningioma | MNDR-E-MI-45559 |
| MNDR | hsa-miR-374a-5p | Gastric adenocarcinoma | MNDR-E-MI-45560 |
| MNDR | hsa-miR-374a-5p | Lung squamous cell carcinoma | MNDR-E-MI-45561 |
| MNDR | hsa-miR-374a-5p | Lung adenocarcinoma | MNDR-E-MI-45562 |
| MNDR | hsa-miR-374a-5p | Adrenocortical cancer | MNDR-E-MI-45563 |
| MNDR | hsa-miR-374a-5p | Thyroid carcinoma | MNDR-E-MI-45564 |
| MNDR | hsa-miR-374a-5p | Bladder urothelial carcinoma | MNDR-E-MI-45565 |
| MNDR | hsa-miR-374a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-45566 |
| MNDR | hsa-miR-374a-5p | Carcinoma renal cell | MNDR-E-MI-45567 |
| MNDR | hsa-miR-374a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-45568 |
| MNDR | hsa-miR-374a-5p | Renal clear cell carcinoma | MNDR-E-MI-45569 |
| MNDR | hsa-miR-374a-5p | Cholangiocarcinoma | MNDR-E-MI-45570 |
| MNDR | hsa-miR-374a-5p | Synovial sarcoma | MNDR-E-MI-45571 |
| MNDR | hsa-miR-374a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-45572 |
| MNDR | hsa-miR-374a-5p | Early hepatocellular carcinoma | MNDR-E-MI-45573 |
| MNDR | hsa-miR-374a-5p | Embryonal cancer | MNDR-E-MI-45574 |
| MNDR | hsa-miR-374a-5p | B-cell lymphoma | MNDR-E-MI-45575 |
| MNDR | hsa-miR-374a-5p | Rheumatoid arthritis | MNDR-E-MI-45576 |
| MNDR | hsa-miR-374a-5p | T-cell leukemia | MNDR-E-MI-45577 |
| MNDR | hsa-miR-374a-5p | Retinoblastoma | MNDR-E-MI-45578 |
| MNDR | hsa-miR-374a-5p | Barrett's adenocarcinoma | MNDR-E-MI-45579 |
| MNDR | hsa-miR-374a-5p | Hodgkin lymphoma | MNDR-E-MI-45580 |
| MNDR | hsa-miR-374a-5p | Burkitt lymphoma | MNDR-E-MI-45581 |
| MNDR | hsa-miR-374a-5p | Psoriasis | MNDR-E-MI-45582 |
| MNDR | hsa-miR-374a-5p | Acute myelocytic leukemia | MNDR-E-MI-45583 |
| MNDR | hsa-miR-374a-5p | Colorectal cancer | MNDR-E-MI-45584 |
| MNDR | hsa-miR-374a-5p | Nasopharynx carcinoma | MNDR-E-MI-45585 |
| MNDR | hsa-miR-374a-5p | Multiple myeloma | MNDR-E-MI-45586 |
| MNDR | hsa-miR-374a-5p | Ovarian epithelial cancer | MNDR-E-MI-45587 |
| MNDR | hsa-miR-374a-5p | Nasopharyngeal cancer | MNDR-E-MI-45588 |
| MNDR | hsa-miR-374a-5p | Epstein-barr virus infections | MNDR-E-MI-45589 |
| MNDR | hsa-miR-374a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-45590 |
| MNDR | hsa-miR-374a-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-45591 |
| MNDR | hsa-miR-374a-5p | Stroke lacunar | MNDR-E-MI-45592 |
| MNDR | hsa-miR-374a-5p | Barrett's carcinogenesis | MNDR-E-MI-45593 |
| MNDR | hsa-miR-374a-5p | High grade dysplastic nodule | MNDR-E-MI-45594 |
| MNDR | hsa-miR-374a-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-45595 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ATM | Homo sapiens | RR00158102 |
TOP